Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab.
Cutaneous squamous cell carcinomas (CSCCs) comprise 20-30% of nonmelanoma skin cancers (NMSCs), and continue to increase in incidence. We report a case of a patient with severe psoriasis who had recurrent and eruptive CSCCs on her leg, which were successfully treated with cetuximab and radiotherapy. The patient had successful long-term clearance of her skin tumours, with the additional finding of resolution of psoriasis while on cetuximab therapy.
Section of Dermatology, University of Chicago, Chicago, IL, USA.
M
M
Kamaria
C R
CR
Shea
R K
RK
Chin
E E
EE
Cohen
R
R
Maggiore
D
D
Bolotin
D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D000068818:Cetuximab; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D006801:Humans; D007866:Leg; D011565:Psoriasis / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab